Epkinly® (epcoritamab-bysp)
for Lymphoma

Epkinly (epcoritamab-bysp) is used to treat adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), high-grade B-cell lymphoma, or follicular lymphoma after two or more prior treatments. It is a bispecific T-cell engager (BiTE) that binds to CD20 on B cells and CD3 on T cells, bringing them together to help T cells kill cancerous B cells more effectively.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Lymphoma